Role of 2 common variants of 5HT2A gene in medication overuse headache

Headache

Volumn 50, Issue 10, 2010, Pages 1587-1596

  Terrazzino, Salvatore ^a   Sances, Grazia ^b   Balsamo, Francesca ^b   Viana, Michele ^c,d   Monaco, Francesco ^c   Bellomo, Giorgio ^a   Martignoni, Emilia ^e   Tassorelli, Cristina ^b   Nappi, Giuseppe ^b   Canonico, Pier Luigi ^a,f   Genazzani, Armando A ^a,f  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f University Centre for Adaptive Disorders and Headache (UCADH)   (Italy)

Author keywords

5HT2A; drug overuse; genetic polymorphism; medication overuse headache; susceptibility

Indexed keywords

BUTALBITAL; CAFFEINE; CODEINE; ERGOT DERIVATIVE; ERGOTAMINE; GENOMIC DNA; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PROCHLORPERAZINE; SEROTONIN 2A RECEPTOR; TRIPTAN DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA EXTRACTION; DRUG ABUSE; DRUG INDUCED HEADACHE; DRUG USE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIMARY HEADACHE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ALLELES; DNA; DRUG-SEEKING BEHAVIOR; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HEADACHE DISORDERS, SECONDARY; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2A; RISK FACTORS; YOUNG ADULT;

EID: 78649279447     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01757.x     Document Type: Article

References (34)

1. Eross E,. Daily headaches due to medication overuse. Neurology. 2003; 60: E8-E9.
2. Diener HC, Limmroth V,. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004; 3: 475-483.
3. Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd ed. (ICHD-II). Revision of criteria for 8.2 medication overuse headache. Cephalalgia. 2005; 25: 460-465.
4. Krymchantowski AV, Barbosa JS,. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia. 2000; 20: 107-113.
5. Uhl GR, Hall FS, Sora I,. Cocaine, reward, movement and monoamine transporters. Mol Psychiatry. 2002; 7: 21-26.
6. Srikiatkhachorn A, Anthony M,. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia. 1996; 16: 423-426.
7. Hering R, Glover V, Pattichis K, Catarci T, Steiner TJ,. 5HT in migraine patients with medication-induced headache. Cephalalgia. 1993; 13: 410-412.
8. Srikiatkhachorn A, Puangniyom S, Govitrapong P,. Plasticity of 5-HT2A serotonin receptor in patients with analgesic-induced transformed migraine. Headache. 1998; 38: 534-539.
9. Lance F, Parkes C, Wilkinson M,. Does analgesic abuse cause headache de novo? Headache. 1988; 38: 61-62.
10. Bahara A, Walsh M, Menon S, Goadsby PJ,. Does chronic daily headache arise de novo in association with regular analgesic use? Headache. 2003; 43: 179-190.
11. Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005; 25: 519-522.
12. Papageorgiou C, Rabavilas A, Liappas I, Stefanis C,. Do obsessive-compulsive patients and abstinent heroin addicts share a common psychophysiological mechanism? Neuropsychobiology. 2003; 47: 1-11.
13. Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache. 2009; 49: 1005-1013.
14. Nicolini H, Arnold P, Nestadt G, Lanzagorta N, Kennedy JL,. Overview of genetics and obsessive-compulsive disorder. Overview of genetics and obsessive-compulsive disorder. Psychiatry Res. 2009; 170: 7-14.
15. Serretti A, Drago A, De Ronchi D,. HTR2A gene variants and psychiatric disorders: A review of current literature and selection of SNPs for future studies. Curr Med Chem. 2007; 14: 2053-2069.
16. Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H,. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav. 2004; 3: 75-79.
17. Enoch MA, Greenberg BD, Murphy DL, Goldman D,. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol. Psychiatry. 2001; 49: 385-388.
18. Nomura M, Nomura Y,. Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann N Y Acad Sci. 2006; 1086: 134-143.
19. Collier DA, Arranz MJ, Li T, Mupita D, Brown N, Treasure J,. Association between 5 and HT gene promoter polymorphism and anorexia nervosa. Lancet. 1997; 350: 412.
20. Inada Y, Yoneda H, Koh J, et al. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res. 2003; 118: 25-31.
21. Nishiguchi N, Matsushita S, Suzuki K, Murayama M, Shirakawa O, Higuchi S,. Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biol Psychiatry. 2001; 50: 123-128.
22. Golimbet VE, Alfimova MV, Mityushina NG,. Polymorphism of the serotonin 2A receptor gene (5HTR2A) and personality traits. Mol Biol. 2004; 38: 404-412.
23. Arranz MJ, Erdmann J, Kirov G, et al. 5-HT2A receptor and bipolar affective disorder: Association studies in affected patients. Neurosci Lett. 1997; 224: 95-98.
24. Skol AD, Scott LJ, Abecasis GR, Boehnke M,. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006; 38: 209-213.
25. Saiz PA, Garcia-Portilla MP, Arango C, et al. Association study between obsessive-compulsive disorder and serotonergic candidate genes. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 765-770.
26. Park JW, Kim JS, Kim YI, Lee KS,. Serotonergic activity contributes to analgesic overuse in chronic tension-type headache. Headache. 2005; 45: 1229-1235.
27. Cevoli S, Mochi M, Scapoli C, et al. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol. 2006; 13: 1009-1013.
28. Cevoli S, Marzocchi N, Capellari S, et al. Lack of association between five serotonin metabolism-related genes and medication overuse headache. J Headache Pain. 2010; 11: 53-58.
29. Di Lorenzo C, Sances G, Di Lorenzo G, et al. The wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett. 2007; 424: 179-184.
30. Di Lorenzo C, Di Lorenzo G, Sances G, et al. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain. 2009; 10: 349-355.
31. Nöthen MM, Rietschel M, Erdmann J, et al. Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet. 1995; 346: 908-909.
32. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC,. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002; 59: 1011-1014.
33. Calabresi P, Cupini LM,. Medication-overuse headache: Similarities with drug addiction. Trends Pharmacol Sci. 2005; 26: 62-68.
34. Fuh JL, Wang SJ, Lu SR, Juang KD,. Does medication overuse headache represent a behavior of dependence? Pain. 2005; 119: 49-55.